About Clinical Trials

We oversee clinical trials conducted in collaboration with industry, government agencies, and academic institutions. Our experience with clinical trials includes Phase II to Phase IV drug and biologics, and pilot, pivotal, and post-market device trials. We currently have more than 425 active studies in diverse therapeutic areas.

Our clinical trials investigators are dedicated practicing physicians from a wide range of therapeutic areas and subspecialties.

Therapeutic areas

Allergy
Anesthesia
Cardiology
Cardiovascular surgery
Dermatology
Electrophysiology
Endocrinology
Family medicine
Gastroenterology
General surgery
Genetics
Gynecological oncology
Head and neck (ENT)
Hematology/Oncology
Hepatology
Infectious disease
Internal medicine
Mental health/Psychiatry
Metabolic disease
Nephrology
Neurology
Neurosurgery
Obstetrics-gynecology
Oncology
Ophthalmology
Optometry
Orthopedics
Pediatrics
Podiatry
Preventive medicine
Psychiatry
Pulmonology
Radiation therapy
Radiology
Radiation oncology
Rheumatology
Transplant
Urology
Urogynecology
Vascular surgery

Our services

The division supports investigators as they initiate and conduct research, providing pre-study, site management, and regulatory support. Learn more about our services.

Clinical trials programs

Kaiser Permanente Southern California leads or participates in several ongoing clinical trials programs.

– Cancer Clinical Trials Access Program (CCTAP)
– Infectious Disease Research Trials Program
– Surgical Radiation Oncology Clinical Trials Access Program (SROCTAP)
– Pediatric Oncology Research Group
– Bone Marrow Transplant Research
– Hepatology Research

For sponsors

Kaiser Permanente Southern California Clinical Trials has extensive experience collaborating with federal, academic, and industry sponsors. Find out more about how we work with sponsors.

 

If you’re interested in learning more about clinical trials at Kaiser Permanente Southern California, please contact:

John Huang
626-564-3620
Clinical.Trials@kp.org